WIN 44,441: A Stereospecific and Long-Acting Narcotic Antagonist

[1]  P. Wood,et al.  Multiple opiate receptor affinities of kappa and agonist/antagonist analgesics: in vivo assessment. , 1983, The Journal of pharmacology and experimental therapeutics.

[2]  P. Wood,et al.  Mu opiate isoreceptors: differentiation with kappa agonists. , 1982, Life sciences.

[3]  J. Morley,et al.  Selective antagonists at the opiate delta-receptor. , 1982, Life sciences.

[4]  J. Dailey,et al.  Effect of adrenalectomy on tyrosine hydroxylase activity , 1982, Neuropharmacology.

[5]  A. M. Lefer,et al.  Beneficial action of a new opiate antagonist (Win 44,441-3) in hemorrhagic shock. , 1982, European journal of pharmacology.

[6]  P. Wood,et al.  High affinity [3H]ethylketazocine binding: Evidence for specific κ receptors , 1982, Neuropharmacology.

[7]  R. Zukin,et al.  Multiple opiate receptors: emerging concepts. , 1981, Life sciences.

[8]  P. Wood,et al.  Multiple opiate receptors: Differential binding of μ, κ and δ agonists , 1981, Neuropharmacology.

[9]  R. Tallarida,et al.  Time course of antagonism of morphine antinociception by intracerebroventricularly administered naloxone in the rat. , 1981, European journal of pharmacology.

[10]  A. Herz,et al.  Demonstration and distribution of an opiate binding site in rat brain with high affinity for ethylketocyclazocine and SKF 10,047. , 1981, Biochemical and biophysical research communications.

[11]  P. Wood,et al.  Spinal analgesia: comparison of the mu agonist morphine and the kappa agonist ethylketazocine. , 1981, Life sciences.

[12]  A. M. Lefer,et al.  Beneficial action of naloxone in splanchnic artery occlusion shock , 1981, Experientia.

[13]  P. Wood,et al.  Actions of kappa, sigma and partial mu narcotic receptor agonists on rat brain acetylcholine turnover , 1981, Neuroscience Letters.

[14]  J. Woods,et al.  Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions. , 1981, Life sciences.

[15]  M. E. Lewis,et al.  Opiate receptor gradients in monkey cerebral cortex: correspondence with sensory processing hierarchies. , 1981, Science.

[16]  T. Duka,et al.  A selective distribution pattern of different opiate receptors in certain areas of rat brain as revealed by in vitro autoradiography , 1981, Neuroscience Letters.

[17]  P. Wood,et al.  Actions of mu, kappa, sigma, delta and agonist/antagonist opiates on striatal dopaminergic function. , 1980, The Journal of pharmacology and experimental therapeutics.

[18]  R. Meibach,et al.  Localization of naloxone-sensitive [3H]dihydromorphine binding sites within the hippocampus of the rat. , 1980, European journal of pharmacology.

[19]  S. Holtzman,et al.  Discriminative stimulus effects of prototype opiate receptor agonists in monkeys. , 1980, European journal of pharmacology.

[20]  P. Wood,et al.  Actions of enkephalin, μ and partial agonist analgesics on acetylcholine turnover in rat brain , 1980, Neuropharmacology.

[21]  T. Petcher,et al.  Bremazocine: a potent, long-acting opiate kappa-agonist. , 1980, Life sciences.

[22]  R. Harris.  Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior. , 1980, The Journal of pharmacology and experimental therapeutics.

[23]  A. Herz,et al.  Dynorphin-related immunoreactive peptides in rat brain and pituitary , 1980, Neuroscience Letters.

[24]  A. Guidotti,et al.  Location and characterization of opiate receptors regulating pituitary secretion. , 1980, Life sciences.

[25]  J. Holaday,et al.  Naloxone treatment of endotoxin shock: stereospecificity of physiologic and pharmacologic effects in the rat. , 1980, The Journal of pharmacology and experimental therapeutics.

[26]  G. Kunos,et al.  NALOXONE REVERSES THE ANTIHYPERTENSIVE EFFECT OF CLONIDINE , 1979, British journal of pharmacology.

[27]  P. Cuatrecasas,et al.  Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity. , 1979, The Journal of biological chemistry.

[28]  I. Creese,et al.  Opiate receptor binding affected differentially by opiates and opioid peptides. , 1979, European journal of pharmacology.

[29]  J. Arndt,et al.  Opiate antagonist reverses the cardiovascular effects of inhalation anaesthesia , 1979, Nature.

[30]  J. Volavka,et al.  Endorphins in psychiatry: an overview and a hypothesis. , 1978, Archives of general psychiatry.

[31]  W. Martin,et al.  The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[32]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[33]  S. Mulé,et al.  Physiological disposition and biotransformation of [allyl-1', 3' - 14C naloxone in the rat and some comparative observations on nalorphine. , 1976, The Journal of pharmacology and experimental therapeutics.

[34]  H. Morris,et al.  Identification of two related pentapeptides from the brain with potent opiate agonist activity , 1975, Nature.

[35]  J. Hughes.  Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine , 1975, Brain Research.

[36]  R. Tombo.  HIGHER EDUCATION IN GERMANY AND THE UNITED STATES. , 1904, Science.

[37]  P. Malek-Ahmadi,et al.  Endorphins and schizophrenia—Narcotic antagonists in the treatment of chronic schizophrenia , 1980 .

[38]  R. Dornbush,et al.  Hormonal and other effects of naltrexone in normal men. , 1979, Advances in experimental medicine and biology.

[39]  J. M. Ree,et al.  Characteristics and function of opioids. , 1978 .